Netherlands Heart Journal

, Volume 18, Issue 12, pp 598–603 | Cite as

Gender differences in coronary heart disease

  • A.H.E.M. Maas
  • Y.E.A. Appelman
Review Article

Cardiovascular disease develops 7 to 10 years later in women than in men and is still the major cause of death in women. The risk of heart disease in women is often underestimated due to the misperception that females are ‘protected’ against cardiovascular disease. The under-recognition of heart disease and differences in clinical presentation in women lead to less aggressive treatment strategies and a lower representation of women in clinical trials. Furthermore, self-awareness in women and identification of their cardiovascular risk factors needs more attention, which should result in a better prevention of cardiovascular events. In this review we summarise the major issues that are important in the diagnosis and treatment of coronary heart disease in women. (Neth Heart J 2010;18:598–603.)


Coronary Heart Disease Gender Differences Menopause Women Risk Factors 


  1. 1.
    Towfighi A, Zheng L, Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med. 2009;169:1762–1766.PubMedCrossRefGoogle Scholar
  2. 2.
    Daly CA, Clemens F, Sendon JL, et al. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina. Eur Heart J. 2005;26:996–1010.PubMedCrossRefGoogle Scholar
  3. 3.
    Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998; 316:1043–1047.PubMedGoogle Scholar
  4. 4.
    Ossewaarde ME, Bots ML, Verbeek AL, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology. 2005;16:556–562.PubMedCrossRefGoogle Scholar
  5. 5.
    Bairey Merz CN, Johnson BD, Sharaf BL, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003;41:413–419.PubMedCrossRefGoogle Scholar
  6. 6.
    Sutton-Tyrell K, Lassila HC, Meilahn E, Bunker C, Matthews KA, Kuller LH. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke. 1998;29:1116–1121.Google Scholar
  7. 7.
    Matthews KA, Meilahn EN, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321:641–646.PubMedCrossRefGoogle Scholar
  8. 8.
    Hochman JS, Tamis, JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med. 1999;341:226–232.PubMedCrossRefGoogle Scholar
  9. 9.
    Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999;341:217–225.PubMedCrossRefGoogle Scholar
  10. 10.
    Grundtvig M, Hagen TP, German M, Reikvam A. Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehab. 2009;16:174–179.CrossRefGoogle Scholar
  11. 11.
    Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. 2009;196:193–222.CrossRefGoogle Scholar
  12. 12.
    Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women. Circulation. 2004;109:706–713.PubMedCrossRefGoogle Scholar
  13. 13.
    Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: metaanalysis of 37 prospective cohort studies. BMJ. 2006;332:73–78.PubMedCrossRefGoogle Scholar
  14. 14.
    Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–313.PubMedGoogle Scholar
  15. 15.
    Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53:688–708.PubMedCrossRefGoogle Scholar
  16. 16.
    Barton M, Meyer MR. Postmenopausal hypertension. Mechanisms and therapy. Hypertension. 2009; 54:1118.CrossRefGoogle Scholar
  17. 17.
    Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291–1297.PubMedCrossRefGoogle Scholar
  18. 18.
    Maas AHEM, Franke HR. Women’s health in menopause with a focus on hypertension. Neth Heart J. 2009;17:69–73.CrossRefGoogle Scholar
  19. 19.
    Ikeda H, Inoue T, Uemura S, Kaibara R, Tanaka H, Node K. Effects of candesartan for middle-aged and elderly women with hypertension and menopausal-like symptoms. Hypertens Res. 2006;29:1007–1012.PubMedCrossRefGoogle Scholar
  20. 20.
    Gast G-CM, Grobbee DE, Pop VJM, Keyzer JJ, Wijnandsvan Gent CJM, Samsioe GN, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008;51:1492–1498.PubMedCrossRefGoogle Scholar
  21. 21.
    Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas. 1999;33:259–269.PubMedCrossRefGoogle Scholar
  22. 22.
    Kannel WB, Castelli WP, Gordon T, McNamar PM. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Intern Med. 1971;74:1–12.PubMedGoogle Scholar
  23. 23.
    Baigent C, Keech A, Kearny PM, Blackwell L, Buck G, Pollicino C, et al. Cholesterol Treatment Trialists collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90.056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267–1278.PubMedCrossRefGoogle Scholar
  24. 24.
    Mizuno K, Nakaya N, Ohashi Y, Tajima N, Kushiro T, Teramoto T, et al. Usefulness of pravastatin in primary prevention of cardiovascular events in women. Analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA-study). Circulation. 2008;117:494–502.PubMedCrossRefGoogle Scholar
  25. 25.
    Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.PubMedCrossRefGoogle Scholar
  26. 26.
    Setji TL, Brown AJ. Polycystic Ovary Syndrome: diagnosis and treatment. Am J Med. 2007; 120:128–132.PubMedCrossRefGoogle Scholar
  27. 27.
    Shaw LJ, Bairey Merz N, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-NHLBI sponsored Women’s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93:1276–1284.PubMedCrossRefGoogle Scholar
  28. 28.
    Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer later in life: systematic review and meta-analysis. BMJ. 2007;335:974–985.PubMedCrossRefGoogle Scholar
  29. 29.
    McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analysis. Am Heart J. 2008;156:918–930.PubMedCrossRefGoogle Scholar
  30. 30.
    Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–1779.PubMedCrossRefGoogle Scholar
  31. 31.
    Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481–1501.PubMedCrossRefGoogle Scholar
  32. 32.
    Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med. 1996;334:1311–1315.PubMedCrossRefGoogle Scholar
  33. 33.
    Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley G, et al. Role of non-invasive testing in the clinical evaluation of women with suspected coronary artery disease. Circulation. 2005;111:682–696.PubMedCrossRefGoogle Scholar
  34. 34.
    Johnson BD, Kelsey SF, Bairey Merz CN. Clinical risk assessment in women: chest discomfort. Report from the WISE study. In: Shaw LJ, Redberg RF editors. CAD in women: evidence-based diagnosis and treatment. Totowa, NJ. Humana Press, 2003:129–142.Google Scholar
  35. 35.
    Pepine CJ, Kerensky RA, Lambert CR, Smith KM, von Mering GO, Sopko G, et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol. 2006;47(suppl): S30–S35.PubMedCrossRefGoogle Scholar
  36. 36.
    Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K, Barrett-Connor E. Prevalence of angina in women versus men. A systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008; 117:1526–1536.PubMedCrossRefGoogle Scholar
  37. 37.
    Shaw LJ, Bugiardini R, Bairey Merz CN. Women and ischemic heart disease. J Am Coll Cardiol. 2009;54:1561–1575.PubMedCrossRefGoogle Scholar
  38. 38.
    Robinson JG, Wallace R, Limacher M, Ren H, Cochrane B, Wassertheil-Smoller S, et al. Cardiovascular risk in women with non-specific chest pain (from the Women’s Health Initiative hormone trials). Am J Cardiol. 2008;102:693–699.PubMedCrossRefGoogle Scholar
  39. 39.
    Humphries KH, Pu A, Gao M, Carere RG, Pilote L. Angina with “normal” coronary arteries: sex differences in outcome. Am Heart J. 2008;155:375–381.PubMedCrossRefGoogle Scholar
  40. 40.
    Morise AP, Olson MB, Bairey Merz NC, Mankad S, Rogers WJ, Pepine CJ, et al. Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLB sponsored Women’s Ischemia Syndrome Evaluation (WISE) study. Am Heart J. 2004;147:1085–1092.PubMedCrossRefGoogle Scholar
  41. 41.
    Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, Reichek N, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141:735–741.PubMedCrossRefGoogle Scholar
  42. 42.
    Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all cause mortality in elderly men and women. J Am Coll Cardiol. 2008;52:17–23.PubMedCrossRefGoogle Scholar
  43. 43.
    Milner KA, Funk M, Richards S, Wilmes RM, Vaccarino V, Krumholz HM. Gender differences in symptom presentation associated with coronary heart disease. Am J Cardiol. 1999;84:396–399.PubMedCrossRefGoogle Scholar
  44. 44.
    Dey S, Flather MD, Devlin G, Brieger D, Gurfunkel EP, Steg PG, et al Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009;95:20–26.PubMedCrossRefGoogle Scholar
  45. 45.
    Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed Diagnoses of Acute Cardiac Ischemia in the Emergency Department. N Engl J Med. 2000;342:1163–1170.PubMedCrossRefGoogle Scholar
  46. 46.
    Milcent C, Dormont B, Durand-Zaleski I, Steg PG. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction. Circulation. 2007;115:833–839.PubMedCrossRefGoogle Scholar
  47. 47.
    Jacobs AK. Coronary intervention in 2009. Are women no different than men? Circ Cardiovasc Intervent. 2009;2:69–78.CrossRefGoogle Scholar
  48. 48.
    Berger JS, Elliott L, Gallup D, Roe M, Granger CB, Armstrong PW, et al. Sex differences in mortality following acute coronary syndromes. JAMA. 2009;302:874–882.PubMedCrossRefGoogle Scholar
  49. 49.
    Clayton TC, Pocock SJ, Henderson RA, Poole-Wilson PA, Shaw TR, Knight R, et al. Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA3 trial. Eur Heart J. 2004;25:1641–1650.PubMedCrossRefGoogle Scholar
  50. 50.
    Donoghue MO, Boden W, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, et al. Early invasive versus conservative treatment strategies in women and men with unstable angina and non-ST-elevation myocardial infarction. JAMA. 2008;300:71–80.CrossRefGoogle Scholar
  51. 51.
    Vaccarino V, Abramson JL, Veledar E, et al. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation. 2002;105:1176–1181.PubMedCrossRefGoogle Scholar
  52. 52.
    Alexander KP, Chen AY, Newby LK, et al. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative. Circulation. 2006;114:1380–1287.PubMedCrossRefGoogle Scholar
  53. 53.
    Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jones JB, et al. The relative efficacy and safety of clopidogrel in women and men. J Am Coll Cardiol. 2009;54:1935–1945.PubMedCrossRefGoogle Scholar
  54. 54.
    Phan A, Shufelt C, Bairey Merx NC. Persistent chest pain and no obstructive coronary artery disease. JAMA. 2009;301:1468–1474.PubMedCrossRefGoogle Scholar
  55. 55.
    Gulati M, Cooper-DeHoff RM, McClure C, Johnson D, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease. A report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women take Heart Project. Arch Intern Med. 2009;169:843–850.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Media / Bohn Stafleu van Loghum 2010

Authors and Affiliations

  • A.H.E.M. Maas
    • 1
  • Y.E.A. Appelman
    • 2
  1. 1.Department of CardiologyIsala ClinicsGK Zwollethe Netherlands
  2. 2.VU Medical CenterAmsterdamthe Netherlands

Personalised recommendations